SHEILA MARIE LOPEZ: Open Payments
NPI 1548030174 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 71 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $858 · 2025 $1,501
Food & beverage: $1,381Education: $120
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $174 |
| Janssen Biotech, Inc. | 10 | $135 |
| EMD Serono, Inc. | 4 | $110 |
| SOBI, INC | 3 | $98 |
| Daiichi Sankyo Inc. | 5 | $91 |
| Celgene Corporation | 4 | $87 |
| PFIZER INC. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Lilly USA, LLC | 2 | $47 |
Products named: RYBREVANT, Doptelet, Enhertu, REBLOZYL, ELREXFIO, Epkinly, DATROWAY, PADCEV.
Industry payments across NV — which companies pay providers there.
